Technology
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Publication and source
PublicationSanalda Haber
SourceArs Technica
Published
CategoryTechnology
Summary from the source publisher’s news feed.